Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
6.70
-0.28 (-4.01%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Avid Bioservices Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Avid Bioservices stock have an average target of 12.25, with a low estimate of 7.00 and a high estimate of 16. The average target predicts an increase of 82.84% from the current stock price of 6.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CDMO stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stephens & Co. | Stephens & Co. | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +79.10% | Mar 11, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +4.48% | Mar 7, 2024 |
RBC Capital | RBC Capital | Buy Maintains $15 → $7 | Buy | Maintains | $15 → $7 | +4.48% | Dec 8, 2023 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $22 → $16 | Strong Buy | Maintains | $22 → $16 | +138.81% | Dec 8, 2023 |
Keybanc | Keybanc | Buy Maintains $20 → $14 | Buy | Maintains | $20 → $14 | +108.96% | Dec 8, 2023 |
Financial Forecast
Revenue This Year
141.68M
from 149.27M
Decreased by -5.08%
Revenue Next Year
169.64M
from 141.68M
Increased by 19.73%
EPS This Year
-0.27
from 0.01
EPS Next Year
-0.03
from -0.27
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 147.9M | 183.8M | 246.8M | 285.0M | 555.2M |
Avg | 141.7M | 169.6M | 219.9M | 263.4M | 539.3M |
Low | 134.3M | 156.8M | 198.0M | 240.1M | 518.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.9% | 29.7% | 45.5% | 29.6% | 110.8% |
Avg | -5.1% | 19.7% | 29.6% | 19.8% | 104.8% |
Low | -10.1% | 10.7% | 16.7% | 9.2% | 96.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.24 | 0.03 | 0.37 |
Avg | -0.27 | -0.03 | 0.24 |
Low | -0.29 | -0.07 | 0.12 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.